Cleveland Clinic’s Dr. Richard Ransohoff Wins 2012 John Dystel Prize for MS Research -- Provided far-reaching insights on immune activity in the central nervous system

Excerpt from the National Multiple Sclerosis Society: (click for entire article)

Professor Richard M. Ransohoff, MD, of the Cleveland Clinic’s Lerner Research Institute and Mellen Center for MS Treatment and Research, has been chosen by a committee of his peers to receive the National MS Society/American Academy of Neurology’s 2012 John Dystel Prize for Multiple Sclerosis Research. Dr. Ransohoff is being honored for pioneering work in MS that led to new insights on immune activity in the brain and spinal cord (neuroimmunology) , particularly the role of messenger proteins known as “chemokines.” The $15,000 prize is being presented at the annual meeting of the American Academy of Neurology in New Orleans in April.

“Dr. Ransohoff has been a galvanizing figure in neuroimmunology research and a true thought leader,” said Benjamin M. Segal, MD (University of Michigan) and Thomas Lane, PhD (University of California, Irvine), who nominated Dr. Ransohoff to receive the Dystel Prize. “The insights that Dr. Ransohoff’s discoveries have provided could ultimately pave the way for the development of a new class of drugs in MS based on chemokines.”